Suzhou Mednovo Yi Medical Technology

Suzhou Mednovo Yi Medical Technology is a specialized subsidiary of the Mednovo Group, a diversified healthcare conglomerate based in Suzhou, China. The company operates at the intersection of medical devices and biotechnology, focusing on minimally invasive interventional products and innovative radiopharmaceuticals. Its clinical pipeline is highlighted by MDN-001, a Yttrium-90 microsphere injection for hepatocellular carcinoma, and a Phase 3 Lutetium [177Lu] oxodotreotide injection for neuroendocrine tumors. Beyond its pharmaceutical interests, Mednovo Yi develops and manufactures various medical devices, including radial artery compression hemostatic devices and microwave ablation systems. The company leverages a dual-driven strategy to address unmet needs in oncology, vascular surgery, and interventional medicine.